1. Home
  2. SCNI vs LICN Comparison

SCNI vs LICN Comparison

Compare SCNI & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • LICN
  • Stock Information
  • Founded
  • SCNI 2003
  • LICN 2004
  • Country
  • SCNI Israel
  • LICN China
  • Employees
  • SCNI N/A
  • LICN N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • LICN
  • Sector
  • SCNI Health Care
  • LICN
  • Exchange
  • SCNI Nasdaq
  • LICN Nasdaq
  • Market Cap
  • SCNI 4.6M
  • LICN 3.8M
  • IPO Year
  • SCNI N/A
  • LICN 2023
  • Fundamental
  • Price
  • SCNI $1.37
  • LICN $4.35
  • Analyst Decision
  • SCNI
  • LICN
  • Analyst Count
  • SCNI 0
  • LICN 0
  • Target Price
  • SCNI N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • SCNI 95.4K
  • LICN 35.0K
  • Earning Date
  • SCNI 11-21-2025
  • LICN 01-01-0001
  • Dividend Yield
  • SCNI N/A
  • LICN N/A
  • EPS Growth
  • SCNI N/A
  • LICN N/A
  • EPS
  • SCNI 0.26
  • LICN N/A
  • Revenue
  • SCNI $1,147,000.00
  • LICN $37,641,000.00
  • Revenue This Year
  • SCNI N/A
  • LICN N/A
  • Revenue Next Year
  • SCNI N/A
  • LICN N/A
  • P/E Ratio
  • SCNI $5.20
  • LICN N/A
  • Revenue Growth
  • SCNI 303.87
  • LICN N/A
  • 52 Week Low
  • SCNI $1.20
  • LICN $2.60
  • 52 Week High
  • SCNI $6.18
  • LICN $462.00
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 45.19
  • LICN 44.20
  • Support Level
  • SCNI $1.32
  • LICN $4.40
  • Resistance Level
  • SCNI $1.63
  • LICN $4.77
  • Average True Range (ATR)
  • SCNI 0.11
  • LICN 0.32
  • MACD
  • SCNI 0.01
  • LICN -0.02
  • Stochastic Oscillator
  • SCNI 38.37
  • LICN 17.07

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: